Healthcare
Pace® Services for Healthcare Organizations Pace® testing and advisory services help healthcare organizations meet strict regulatory standards and ensure the […]
Life Sciences
Uncategorized
Interview with Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical Development Pace® Life Sciences
Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical DevelopmentPace® Life Sciences were recently interviewed
Uncategorized
ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy
Pace ® is happy to share news from our client, ReveraGen BioPharma Inc., on a significant accomplishment! ReveraGen Completes NDA
Uncategorized
Pace® Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy and Consulting Capabilities to the Biotechnology and Pharmaceutical Markets
Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of
Uncategorized
First Wave BioPharma Finalizes Selection of Adrulipase Microgranule Drug Delivery Formulation
First Wave BioPharma Chooses Pace® Life Sciences as CDMO Partner. BOCA RATON, Fla., Sept. 07, 2022 (GLOBE NEWSWIRE) — First
Uncategorized
First Wave BioPharma Announces AAPS 2022 PharmSci 360 Accepts Adrulipase Formulation Abstract
Research involves microgranule delivery formulations for adrulipase BOCA RATON, Fla., Aug. 31, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc.,
Uncategorized
Pace® Life Sciences Acquires Meridian BioGroup, Expanding Regulatory, Compliance, and Validation Capabilities to the Biotechnology and Pharmaceutical Markets
Acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve
Uncategorized
Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Sustainability Efforts
Company excels in Labor & Human Rights and Ethics performance for current Corporate Social Responsibility (CSR) Initiatives. Pace® Life Sciences,
Webinar: The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf
Pharmaceutical Technology hosts “The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf” – a webinar
Uncategorized
Getting Drugs to Market – Dr Frank Tagliaferri, Pace Life Sciences
Frank Tagliaferri, Ph.D., Vice President of Pharmaceutical Development sat down with BioProcess International to discuss the growth the industry, and